Motivation: In prognosis and survival studies, an important goal is to identify multi-biomarker panels with predictive power using molecular characteristics or clinical observations.Such analysis is often challenged by censored, small-sample-size, but high-dimensional genomic profiles or clinical data.Therefore, sophisticated models and algorithms are in pressing need.